# Kazakhstan Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Kazakhstan HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Kazakhstan (KAZ)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $407.3M
- Products: 26
- Buyer markets: 24
- Average CAGR: +137.7%
- Global sector size: $480.4B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $286.3B | $20.1M | $109.0B | +4.3% | 18 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $27.1B | $20.7M | $17.9B | +30.9% | 9 | +0.3% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $40.5B | $45.8K | $17.0B | +24.8% | 5 | +0.0% |
| HS 284190 - Salts of oxometallic or peroxometallic acids: n.e.c. in heading no. 2841 | $6.6B | $1.0M | $9.7B | +3.8% | 4 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.4B | $109.1K | $8.8B | +22.2% | 5 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $18.7B | $819.0K | $8.3B | +73.3% | 5 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $10.9B | $35.3K | $7.8B | +12.9% | 4 | +0.0% |
| HS 290243 - Cyclic hydrocarbons: p-xylene | $8.5B | $22.7M | $6.2B | +25.2% | 1 | +0.3% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $11.3B | $139.8K | $6.0B | +22.2% | 2 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $12.6K | $5.0B | -12.1% | 3 | +0.0% |
| HS 293379 - Heterocyclic compounds: lactams: other than 6-hexanelactam (epsilon caprolactam) | $4.2B | $1.4K | $4.8B | +2847.8% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $5.8B | $8.9K | $4.6B | +2017.4% | 1 | +0.0% |
| HS 290220 - Cyclic hydrocarbons: benzene | $4.1B | $2.6M | $3.5B | +34.5% | 1 | +0.1% |
| HS 293359 - Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $3.5B | $5.3K | $3.2B | +2318.3% | 1 | +0.0% |
| HS 284420 - Uranium: enriched in U235, plutonium, their compounds, alloys dispersions (including cermets), ceramic products and mixtures containing uranium enriched in U235, plutonium or compounds of these products | $5.9B | $37.4M | $3.0B | +8.9% | 2 | +1.5% |
| HS 382319 - Industrial monocarboxylic fatty acids: acid oils from refining: (other than stearic acid, oleic acid or tall oil fatty acids) | $1.3B | $143.3K | $1.9B | +30.4% | 1 | +0.0% |
| HS 284690 - Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | $1.4B | $167.6K | $1.5B | -7.6% | 1 | +0.0% |
| HS 300670 - Pharmaceutical goods: Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments | $1.2B | $27.7 | $1.4B | -15.0% | 1 | +0.0% |
| HS 310420 - Fertilizers, mineral or chemical: potassic, potassium chloride | $3.3B | $81.8 | $1.4B | -21.7% | 1 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $24.0K | $1.1B | +70.6% | 1 | +0.1% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $1.6B | $301.4M | $1.1B | +10.0% | 1 | +19.2% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $8.0 | $1.0B | -14.2% | 1 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $1.5B | $12.1K | $1.0B | -26.7% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $124.4 | $981.1M | -12.5% | 1 | +0.0% |
| HS 280461 - Silicon: containing by weight not less than 99.99% of silicon | $839.5M | $51.6 | $927.8M | -70.2% | 1 | +0.0% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $4.1K | $871.2M | +1818.7% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $35.4B calculated opportunity across 9 products.
- China (CHN): $34.4B calculated opportunity across 12 products.
- Switzerland, Liechtenstein (CHE): $33.3B calculated opportunity across 3 products.
- Germany (DEU): $33.2B calculated opportunity across 12 products.
- Netherlands (NLD): $12.9B calculated opportunity across 4 products.
- Slovenia (SVN): $12.8B calculated opportunity across 2 products.
- United Kingdom (GBR): $8.1B calculated opportunity across 3 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- France (FRA): $6.6B calculated opportunity across 4 products.
- Spain (ESP): $6.6B calculated opportunity across 2 products.
- Canada (CAN): $4.9B calculated opportunity across 2 products.
- Italy (ITA): $4.9B calculated opportunity across 1 products.

## Growth stars

- HS 293379: +2847.8% average CAGR, $4.8B calculated opportunity.
- HS 293359: +2318.3% average CAGR, $3.2B calculated opportunity.
- HS 293499: +2017.4% average CAGR, $4.6B calculated opportunity.
- HS 293339: +1818.7% average CAGR, $871.2M calculated opportunity.
- HS 382200: +73.3% average CAGR, $8.3B calculated opportunity.
- HS 321590: +70.6% average CAGR, $1.1B calculated opportunity.
- HS 290220: +34.5% average CAGR, $3.5B calculated opportunity.
- HS 382499: +30.9% average CAGR, $17.9B calculated opportunity.
- HS 382319: +30.4% average CAGR, $1.9B calculated opportunity.
- HS 290243: +25.2% average CAGR, $6.2B calculated opportunity.

## Diversification opportunities

- HS 300490: 18 buyer markets, $109.0B calculated opportunity.
- HS 382499: 9 buyer markets, $17.9B calculated opportunity.
- HS 300215: 5 buyer markets, $17.0B calculated opportunity.
- HS 330499: 5 buyer markets, $8.8B calculated opportunity.
- HS 382200: 5 buyer markets, $8.3B calculated opportunity.
- HS 284190: 4 buyer markets, $9.7B calculated opportunity.
- HS 300439: 4 buyer markets, $7.8B calculated opportunity.
- HS 330300: 3 buyer markets, $5.0B calculated opportunity.
- HS 300212: 2 buyer markets, $6.0B calculated opportunity.
- HS 284420: 2 buyer markets, $3.0B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.